These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9422361)

  • 1. In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions.
    Hoffman AF; Gerhardt GA
    J Neurochem; 1998 Jan; 70(1):179-89. PubMed ID: 9422361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
    Hoffman AF; Lupica CR; Gerhardt GA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):487-96. PubMed ID: 9808671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
    Zahniser NR; Larson GA; Gerhardt GA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease.
    Kamińska K; Lenda T; Konieczny J; Wardas J; Lorenc-Koci E
    Neurochem Int; 2018 Dec; 121():125-139. PubMed ID: 30290201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo electrochemical studies of dopamine clearance in subregions of rat nucleus accumbens: differential properties of the core and shell.
    David DJ; Zahniser NR; Hoffer BJ; Gerhardt GA
    Exp Neurol; 1998 Oct; 153(2):277-86. PubMed ID: 9784287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependency of the dopamine transporter in the rat substantia nigra.
    Hoffman AF; Zahniser NR; Lupica CR; Gerhardt GA
    Neurosci Lett; 1999 Jan; 260(2):105-8. PubMed ID: 10025710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
    Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
    Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum.
    van Horne C; Hoffer BJ; Strömberg I; Gerhardt GA
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1285-92. PubMed ID: 1469634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.
    Hoffman AF; van Horne CG; Eken S; Hoffer BJ; Gerhardt GA
    Exp Neurol; 1997 Sep; 147(1):130-41. PubMed ID: 9294410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of dopamine release and clearance to 6-hydroxydopamine lesioning in rat striatum.
    Wang Y; Tang FI; Chiou AL; Wang JY
    Life Sci; 1996; 59(21):1783-92. PubMed ID: 8937505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
    Budygin EA; John CE; Mateo Y; Jones SR
    J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
    Nirenberg MJ; Vaughan RA; Uhl GR; Kuhar MJ; Pickel VM
    J Neurosci; 1996 Jan; 16(2):436-47. PubMed ID: 8551328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
    Chen BT; Rice ME
    J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
    Chotibut T; Apple DM; Jefferis R; Salvatore MF
    PLoS One; 2012; 7(12):e52322. PubMed ID: 23300642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration.
    Burchett SA; Bannon MJ
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):95-102. PubMed ID: 9387868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.